Our research highlights serve as a collection of feature articles detailing recent scientific achievements on GCS HPC resources. 

The mRNA vaccine for COVID-19 was the first of its kind, demonstrating the potential of a new biomedical paradigm. Computational research at the Johannes Gutenberg University Mainz could open new opportunities for mRNA-based medicines.

High-performance computing enables bioengineers to predict how laboratory results can be transferred to industrial conditions without loss of performance.

High-performance computing provides essential tools for drug discovery and epidemiological modeling in the fight against the global pandemic.